• 1
    Stewart WF, Lipton RB, Liberman J. Variation in migraine prevalence by race. Neurology. 1996;47:529.
  • 2
    Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41: 64657.
  • 3
    Lipton RB, Stewart WF, Kolodner KB, Liberman JN. Epidemiology and patterns of health care use for migraine in the United States. Headache. 1999;39: 656.
  • 4
    Hu XH, Markson LE, Lipton RB, Stewart WF, Berger ML. Burden of migraine in the United States: disability and economic costs. Arch Intern Med. 1999;159: 8138.
  • 5
    Stang PE, Osterhaus JT, Celentano DD. Migraine. Patterns of healthcare use. Neurology. 1994;44(6 suppl 4):S47S55.
  • 6
    Kolodner K, Lipton RB, Elston Lafata J, et al. Pharmacy and medical claims data identified migraine sufferers with high specificity but modest sensitivity. J Clin Epidemiol. 2004. In press.
  • 7
    Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;47: 63845.
  • 8
    Celentano DD, Stewart WF, Lipton RB, Reed ML. Medication use and disability among migraineurs: a national probability sample survey. Headache. 1992;32: 2238.
  • 9
    Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology. 1999;53: 98894.
  • 10
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders: cranial neuralgias and facial pain. Cephalalgia. 1998;8: 1928.
  • 11
    Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers. Pain. 2000;88: 4152.
  • 12
    Stewart WF, Lipton RB, Sawyer J. A multi-national study to assess the reliability of the migraine disability assessment (MIDAS) score. Headache. 1998;38: 407.
  • 13
    Ware JE, Gandek B. The SF-36 health survey: development and use in mental health and the IQOLA Project. Int J Ment Health. 1994;23: 4973.
  • 14
    Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999;282: 173744.
  • 15
    Melfi CA, Croghan TW. Use of claims data for research on treatment and outcomes of depression care. Med Care. 1999;37(4 suppl):AS77AS80.
  • 16
    Simon G, Ormel J, VonKorff M, Barlow W. Health care costs associated with depressive and anxiety disorders in primary care. Am J Psychiatry. 1995;152: 3527.
  • 17
    Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK. Physician office visits of adults for anxiety disorders in the United States, 1985–1998. J Gen Intern Med. 2002;17: 16572.
  • 18
    Deyo RA, Taylor VM, Diehr P, et al. Analysis of automated administrative and survey databases to study patterns and outcomes of care. Spine. 1994;19(suppl 18):2083S2091S.
  • 19
    Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154: 85464.
  • 20
    Savage IR. Contributions to the theory of rank order statistics—the two sample case. Ann Math Stat. 1956;27: 590615.
  • 21
    Duan N, Manning WG, Morris CN, Newhouse JP. A comparison of alternative models for the demand for medical care. J Bus Econ Stat. 1983;1: 11526.
  • 22
    Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20: 46194.
  • 23
    Breslau N, Schultz LR, Stewart WF, Lipton RB, Lucia VC, Welch KM. Headache and major depression: is the association specific to migraine? Neurology. 2000;54: 30813.
  • 24
    Breslau N. Migraine comorbidity with stroke, epilepsy and major depression. In OlesenJ, SteinerTJ, LiptonRB, eds. Reducing the Burden of Headache. Oxford: Oxford University Press; 2003: 16472.
  • 25
    Clouse JC, Osterhaus JT. Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother. 1994;28: 65964.
  • 26
    Edmeads J, Mackell JA. The economic impact of migraine: an analysis of direct and indirect costs. Headache. 2002;42: 5019.
  • 27
    Linet MS, Celentano DD, Stewart WF. Headache characteristics associated with physician consultation: a population-based survey. Am J Prev Med. 1991;7: 406.
  • 28
    Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41: 85461.
  • 29
    Lipton RB, Stewart WF, Celentano DD, Reed ML. Undiagnosed migraine headaches. A comparison of symptom-based and reported physician diagnosis. Arch Intern Med. 1992;152: 12738.
  • 30
    Von Korff M, Wagner EH, Dworkin SF, Saunders KW. Chronic pain and use of ambulatory health care. Psychosom Med. 1991;53: 6179.
  • 31
    Stewart WF, Lipton RB. Migraine headache: epidemiology and health care utilization. Cephalalgia. 1993;13(suppl 12):416.
  • 32
    Rasmussen BK, Olesen J. Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia. 1992;12: 2218.
  • 33
    Lipton RB, Stewart WF, Von Korff M. The burden of migraine. A review of cost to society. Pharmacoeconomics. 1994;6: 21521.
  • 34
    Von Korff M, Stewart WF, Lipton RB. Assessing headache severity. New directions. Neurology. 1994;44(6 suppl 4):S40S46.
  • 35
    Ramadan NM, Silberstein S, Freitag F, Gilbert TT, Frishberg BM. Evidence based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Available at: Accessed March 1, 2003.
  • 36
    Lipton RB, Silberstein S. Why study the comorbidity of migraine? Neurology. 1994;44: 2832.
  • 37
    Silberstein S, Lipton RB. Chronic daily headache, including transformed migraine, chronic tension type headache and medication overuse. In: Silberstein S, Lipton RB, Dalessio DJ, eds. Wolff's Headache and other Head Pain. New York, NY: Oxford University Press; 2001: 24782.
  • 38
    Centers for Disease Control and Prevention. Colorectal cancer test use among persons aged ≥ 50 years—United States, 2001. MMWR. 2003;52: 1936 .
  • 39
    Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia. 2000;20: 55460.
  • 40
    Dasbach EJ, Carides GW, Gerth WC, Santanello NC, Pigeon JG, Kramer M. Work and productivity loss in the rizatriptan multiple attack study. Cephalalgia. 2000;29: 8304.
  • 41
    Cady RK, Sheftell F, Lipton RB, Kwong WJ, O'Quinn S. Economic implications of early treatment of migraine with sumatriptan tablets. Clin Ther. 2001;23: 28491.
  • 42
    Stang P, Cady R, Batenhorst A, Hoffman L. Workplace productivity. A review of the impact of migraine and its treatment. Pharmacoeconomics. 2001;19: 23144.